Thyroid Hormone Induces Terminal Differentiation of Tumor Cells in Medulloblastoma
Thyroid Hormone Induces Terminal Differentiation of Tumor Cells in Medulloblastoma
Dr. Zeng-jie Yang – The Research Institute of Fox Chase Cancer Center, Philadelphia, PA
Targeting the HMGA1 Chromatin Regulator in MLL1-Rearranged Pediatric Leukemia
Targeting the HMGA1 Chromatin Regulator in MLL1-Rearranged Pediatric Leukemia
Dr. Linda Resar – Johns Hopkins University School of Medicine, Baltimore, MD
Deciphering the Immune Microenvironment in Alveolar Rhabdomyosarcoma
Deciphering the Immune Microenvironment in Alveolar Rhabdomyosarcoma
Dr. Brian Ladle - Johns Hopkins University School of Medicine, Baltimore, MD
Delineating molecular mechanisms of metastatic dissemination for medulloblastoma therapy
Delineating molecular mechanisms of metastatic dissemination for medulloblastoma therapy
Dr. Baoli Hu – University of Pittsburgh, Pittsburgh, PA
Dual-label optical genome mapping for the identification of novel co-occurring genetic and epigenetic alterations in diffuse midline gliomas
Dual-label optical genome mapping for the identification of novel co-occurring genetic and epigenetic alterations in diffuse midline gliomas
Dr. Miriam Bornhorst – Children's National Health System Department of Neurology, Washington D.C.
Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma
Preclinical evaluation of BRD inhibitors to treat Posterior Fossa A ependymoma
Dr. Oren Becher – Icahn School of Medicine at Mount Sinai, New York, NY
Epigenetic targeting of radiation resistant medulloblastoma
Epigenetic targeting of radiation resistant medulloblastoma
Johns Hopkins University, Baltimore, MD
Therapeutical reprogramming of DIPG cells
Therapeutical reprogramming of DIPG cells
Joan & Sanford I. Weill Medical College of Cornell University, New York, NY
T cell immunotherapy targeting fusion-derived “public” neoantigens expressed by pediatric desmoplastic small round cell tumors
T cell immunotherapy targeting fusion-derived “public” neoantigens expressed by pediatric desmoplastic small round cell tumors
Memorial Sloan Kettering Cancer Center (MSK), New York, NY
MYCN-amplified neuroblastoma are addicted to iron and vulnerable to system Xc- inhibition
MYCN-amplified neuroblastoma are addicted to iron and vulnerable to system Xc- inhibition
Virginia Commonwealth University, Richmond, VA
The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model
The role of inflammation in the liver microenvironment of a Fibrolamellar Carcinoma zebrafish model
Albert Einstein College of Medicine, New York, NY
Exploiting NAD Metabolism Defects in Pediatric Brain Tumors
Exploiting NAD Metabolism Defects in Pediatric Brain Tumors
Yale University, New Haven, CT
Understanding the role of SMARCD1(BAF60A) in malignant rhabdoid
Understanding the role of SMARCD1(BAF60A) in malignant rhabdoid
Trustees of Dartmouth College, Lebanon, NH
Arginine methylation as a potential therapeutic target in high-risk neuroblastoma
Arginine methylation as a potential therapeutic target in high-risk neuroblastoma
University of Rochester, Rochester, NY
Clinical Trial Decision Aid (DECIDES) for Adolescents and Young Adults with Cancer and their Caregivers
Clinical Trial Decision Aid (DECIDES) for Adolescents and Young Adults with Cancer and their Caregivers
Children’s Hospital of Philadelphia, Philadelphia, PA
Activation of NF-kB in Neuroblastoma Myeloid Cells
Activation of NF-kB in Neuroblastoma Myeloid Cells
Johns Hopkins University School of Medicine, Baltimore, MD
Molecular Mechanism of CAR Activation in Targeting B Cell Leukemia
Molecular Mechanism of CAR Activation in Targeting B Cell Leukemia
Yale University, New Haven, CT
Disrupting Neuroblastoma Tumor-Initiating Cells
Disrupting Neuroblastoma Tumor-Initiating Cells
University of Rochester, Rochester, NY
Preclinical Development of Novel Immunotherapies for Pediatric Acute Myeloid Leukemia (AML)
Preclinical Development of Novel Immunotherapies for Pediatric Acute Myeloid Leukemia (AML)
Children’s Hospital of Philadelphia, Philadelphia, PA
Tumorigenesis of a Pediatric Liver Cancer
Tumorigenesis of a Pediatric Liver Cancer
The Rockefeller University, New York, NY